Raymond James & Associates’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-440
| Closed | -$18K | – | 3948 |
|
|
2022
Q1 | $18K | Buy |
440
+170
| +63% | +$6.96K | ﹤0.01% | 3894 |
|
|
2021
Q4 | $14K | Buy |
+270
| New | +$14K | ﹤0.01% | 3942 |
|
|
2019
Q4 | – | Sell |
-340
| Closed | -$11K | – | 3589 |
|
|
2019
Q3 | $11K | Buy |
340
+90
| +36% | +$2.91K | ﹤0.01% | 3472 |
|
|
2019
Q2 | $11K | Buy |
+250
| New | +$11K | ﹤0.01% | 3489 |
|
|
2017
Q2 | – | Sell |
-709
| Closed | -$98K | – | 3231 |
|
|
2017
Q1 | $98K | Buy |
+709
| New | +$98K | ﹤0.01% | 3029 |
|